|
|
Time |
Source |
|
Announcement
|
|
| 31 Jul 2018 |
7:00 am |
GNW
|
|
|
TiGenix (0EIT) |
Takeda Completes its Acquisition of TiGenix Following Expiration of the Squeeze-out Period |
| 23 Jul 2018 |
9:00 pm |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007 |
| 06 Jul 2018 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
Takeda and TiGenix Announce Results of Second Acceptance Period for the Voluntary and Conditional Public Takeover Bid |
| 02 Jul 2018 |
9:00 pm |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix: Transparency Information |
| 27 Jun 2018 |
9:00 pm |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007 |
| 22 Jun 2018 |
9:00 pm |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007 |
| 19 Jun 2018 |
9:00 pm |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 |
| 14 Jun 2018 |
9:00 pm |
GNW
|
|
|
TiGenix (0EIT) |
Transparency notification pursuant to Article 14 of the Law of May 2, 2007 |
| 13 Jun 2018 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix announces a change in its Board of Directors and its Management Team |
| 06 Jun 2018 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
Takeda and TiGenix Announce Results of First Acceptance Period for the Voluntary and Conditional Public Takeover Bid of TiGenix and Commencement of Second Acceptance Period |
| 28 May 2018 |
9:00 pm |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 |
| 14 May 2018 |
9:00 pm |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix:Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 |
| 08 May 2018 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix: CONVENING NOTICE TO THE ANNUAL SHAREHOLDERS' MEETING TO BE HELD ON 7 JUNE 2018 |
| 13 Apr 2018 |
9:00 pm |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007 |
| 12 Apr 2018 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix reports 2017 full year results |
| 10 Apr 2018 |
9:00 pm |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 |
| 30 Mar 2018 |
9:00 pm |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 |
| 23 Mar 2018 |
5:00 pm |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix and Takeda announce Alofisel® (darvadstrocel) receives approval to treat complex perianal fistulas in Crohn's disease in Europe |
| 06 Feb 2018 |
9:00 pm |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix: Transparency Information |
| 31 Jan 2018 |
9:00 pm |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 |
| 26 Jan 2018 |
9:00 pm |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix:Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 |
| 19 Jan 2018 |
9:00 pm |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix: Transparency Information |
| 18 Jan 2018 |
9:00 pm |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007 |
| 16 Jan 2018 |
9:00 pm |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 |
| 15 Jan 2018 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix announces publication in Gastroenterology of 52-week results of the Phase III ADMIRE-CD trial of Cx601 |
| 12 Jan 2018 |
9:00 pm |
GNW
|
|
|
TiGenix (0EIT) |
Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 |
| 11 Jan 2018 |
9:00 pm |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix: Transparency Information |
| 05 Jan 2018 |
6:30 am |
GNW
|
|
|
TiGenix (0EIT) |
Takeda announces its intention to acquire TiGenix |
| 03 Jan 2018 |
9:00 pm |
GNW
|
|
|
TiGenix (0EIT) |
Transparency notification pursuant to Article 14 of the Law of May 2, 2007 |
| 20 Dec 2017 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix confirms strategic focus on Cx601 and its adipose derived stem cell (eASC) platform |
| 15 Dec 2017 |
12:11 pm |
GNW
|
|
|
TiGenix (0EIT) |
Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn's disease |
| 14 Dec 2017 |
11:21 pm |
GNW
|
|
|
TiGenix (0EIT) |
Mesoblast grants TiGenix an exclusive global patent license to use adipose-derived mesenchymal stem cells in the local treatment of fistulae |
| 24 Nov 2017 |
9:00 pm |
GNW
|
|
|
TiGenix (0EIT) |
JPMorgan Chase & Co notifies 3.12% shareholding in TiGenix |
| 20 Nov 2017 |
8:31 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix to present positive 52-week Phase III Cx601 data at EHA-SWG Scientific Meeting |
| 16 Nov 2017 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix announces approval of trade name for lead development candidate Cx601 in Europe |
| 06 Nov 2017 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix announces partial conversion of bonds |
| 02 Nov 2017 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix strengthens European IP protection around lead development program Cx601 |
| 31 Oct 2017 |
6:01 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix provides regulatory update on Cx601 EU Marketing Authorization Application procedure |
| 23 Oct 2017 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix granted Orphan Drug Designation from the U.S. FDA for Cx601 |
| 05 Oct 2017 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix to present positive 52-week Phase III results of Cx601 at World Congress of Gastroenterology at ACG 2017 meeting |
| 02 Oct 2017 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix to host Analyst and Investor Event in New York City |
| 28 Sep 2017 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix to participate and present at key investor and business development meetings |
| 19 Sep 2017 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix Business and Financial Update for the First Half 2017 |
| 12 Sep 2017 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix strengthens US operations with senior appointments |
| 05 Sep 2017 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix obtains commercial production license for expanded manufacturing facility |
| 23 Jun 2017 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix to present at the 7th TERMIS-EU Conference in Davos, Switzerland |
| 20 Jun 2017 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
Takeda and TiGenix announce that Swissmedic has accepted for review the file on Cx601 for the treatment of complex perianal fistulas in Crohn's disease patients |
| 15 Jun 2017 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix Partners with U.S. and European Patient Advocacy Groups Focused on Crohn's Disease and Ulcerative Colitis |
| 13 Jun 2017 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix Launches Global Phase III Trial for Cx601 |
| 12 Jun 2017 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix announces final equity payment for cardiac platform acquisition |
| 01 Jun 2017 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix to present at the Jefferies 2017 Global Healthcare Conference in New York |
| 31 May 2017 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix provides regulatory update on Cx601 EU Marketing Authorization Application procedure |
| 11 May 2017 |
6:03 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix to present at Bank of America Merrill Lynch 2017 Healthcare Conference in Las Vegas |
| 10 May 2017 |
6:02 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix to present at the Crohn's and Colitis Foundation's Novel Technologies in Inflammatory Bowel Disease workshop in New York |
| 04 May 2017 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix Cx601 positive long-term results to be presented at Digestive Disease Week |
| 02 May 2017 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix: CONVENING NOTICE TO THE ANNUAL SHAREHOLDERS' MEETING TO BE HELD ON 1 JUNE 2017 |
| 06 Apr 2017 |
6:01 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix reports 2016 full year results |
| 05 Apr 2017 |
6:01 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix to participate in key investor conferences in April 2017 |
| 13 Mar 2017 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix Announces Top-Line Phase I/II Results of AlloCSC-01 in Acute Myocardial Infarction |
| 09 Mar 2017 |
6:00 am |
GNW
|
|
|
TiGenix (0EIT) |
TiGenix Announces Positive Topline Week-104 Data for Cx601 ADMIRE-CD Trial |